These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2832309)

  • 41. Dendritic cells presenting equine herpesvirus-1 antigens induce protective anti-viral immunity.
    Steinbach F; Borchers K; Ricciardi-Castagnoli P; Ludwig H; Stingl G; Elbe-Bürger A
    J Gen Virol; 1998 Dec; 79 ( Pt 12)():3005-14. PubMed ID: 9880015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigenic relatedness of equine herpes virus types 1 and 3.
    Gutekunst DE; Malmquist WA; Becvar CS
    Arch Virol; 1978; 56(1-2):33-45. PubMed ID: 75724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of viral loads, strain and state of equine herpesvirus-1 using real-time PCR in horses following natural exposure at a racetrack in California.
    Pusterla N; Wilson WD; Mapes S; Finno C; Isbell D; Arthur RM; Ferraro GL
    Vet J; 2009 Feb; 179(2):230-9. PubMed ID: 18024200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?
    Rosas CT; Goodman LB; von Einem J; Osterrieder N
    Expert Rev Vaccines; 2006 Feb; 5(1):119-31. PubMed ID: 16451114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.
    Paillot R; Ellis SA; Daly JM; Audonnet JC; Minke JM; Davis-Poynter N; Hannant D; Kydd JH
    Vaccine; 2006 Mar; 24(10):1490-500. PubMed ID: 16269205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural proteins of equine infectious anemia virus and their antigenic activity.
    Nishimura M; Nakajima H
    Am J Vet Res; 1984 Jan; 45(1):5-10. PubMed ID: 6322625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Equine herpesvirus type 2: cell-virus relationship during persistent cell-associated viremia.
    Gleeson LJ; Coggins L
    Am J Vet Res; 1985 Jan; 46(1):19-23. PubMed ID: 2982296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG).
    von Einem J; Smith PM; Van de Walle GR; O'Callaghan DJ; Osterrieder N
    Virology; 2007 May; 362(1):151-62. PubMed ID: 17250864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cellular and antibody responses to equine herpesviruses 1 and 4 following vaccination of horses with modified-live and inactivated viruses.
    Ellis JA; Bogdan JR; Kanara EW; Morley PS; Haines DM
    J Am Vet Med Assoc; 1995 Mar; 206(6):823-32. PubMed ID: 7538990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH; Townsend HG; Hannant D
    Vet Immunol Immunopathol; 2006 May; 111(1-2):15-30. PubMed ID: 16476492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new field strain of equine abortion virus (equine herpesvirus-1) among Kentucky horses.
    Allen GP; Yeargan MR; Turtinen LW; Bryans JT
    Am J Vet Res; 1985 Jan; 46(1):138-40. PubMed ID: 2982294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A hamster model of equine herpesvirus type 1 (EHV-1) infection; passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18.
    Stokes A; Allen GP; Pullen LA; Murray PK
    J Gen Virol; 1989 May; 70 ( Pt 5)():1173-83. PubMed ID: 2471805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoclonal antibodies with neutralizing activity to equine herpesvirus 1.
    Shimizu M; Satou K; Nishioka N
    Arch Virol; 1989; 104(1-2):169-74. PubMed ID: 2538111
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protection against lethal equine herpes virus type 1 (subtype 1) infection in hamsters by immune stimulating complexes (ISCOMs) containing the major viral glycoproteins.
    Cook RF; O'Neill T; Strachan E; Sundquist B; Mumford JA
    Vaccine; 1990 Oct; 8(5):491-6. PubMed ID: 2174599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular pathogenesis of equine coital exanthema: identification and expression of infected cell polypeptides at the restricted temperature during equine herpesvirus 3 infection.
    Jacob RJ; Steiner MR
    Vet Microbiol; 1988 Dec; 18(3-4):363-71. PubMed ID: 2852875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The characterization of neutralizing and non-neutralizing monoclonal antibodies against equid herpesvirus type 1.
    Sinclair R; Cook RF; Mumford JA
    J Gen Virol; 1989 Feb; 70 ( Pt 2)():455-9. PubMed ID: 2543748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and processing of equine herpesvirus type 1 glycoprotein 14.
    Sullivan DC; Allen GP; O'Callaghan DJ
    Virology; 1989 Dec; 173(2):638-46. PubMed ID: 2556845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of herpesvirus sylvilagus glycoproteins released into the culture medium of infected cells: antisera to gp13 and gp32 neutralize viral infectivity in vitro and identify antigens on plasma membranes of infected cells.
    Patick AK; Hinze HC
    J Virol; 1987 Nov; 61(11):3580-8. PubMed ID: 3312635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Equine herpesvirus type 1 infected cell polypeptides: evidence for immediate early/early/late regulation of viral gene expression.
    Caughman GB; Staczek J; O'Callaghan DJ
    Virology; 1985 Aug; 145(1):49-61. PubMed ID: 2990102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of the acid-soluble polypeptides of five herpesviruses.
    Halliburton IW; Freeman MJ
    J Gen Virol; 1985 Oct; 66 ( Pt 10)():2243-8. PubMed ID: 2995559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.